Sagetis Biotech Overview
- Year Founded
-
2010
- Status
-
Out of Business
- Employees
-
2
- Latest Deal Type
-
Out of Business
Sagetis Biotech General Information
Description
Operator of a drug delivery and polymeric technology development company intended to treat diseases of the central nervous system. The company develops polymer-coated adenovirus release systems that allow the administration of drugs to treat diseases of the central nervous system against pre-existing neutralizing antibodies, by masking their surface antigenic epitopes and preserving their transduction capability, for the treatment of pancreatic ductal adenocarcinoma, thereby enabling healthcare professionals to modify the behavior of oncolytic viruses, improving their therapeutic effect by different means.
Contact Information
Website
www.sagetis-biotech.comCorporate Office
- 394 Via Augusta
- 08017 Barcelona
- Spain
Corporate Office
- 394 Via Augusta
- 08017 Barcelona
- Spain
Sagetis Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Out of Business | 09-Jul-2021 | Completed | Out of Business | |||
| 4. Grant | 22-Dec-2017 | Completed | Generating Revenue | |||
| 3. Seed Round | 15-Jul-2013 | Completed | Generating Revenue | |||
| 2. Seed Round | 15-Dec-2011 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 01-Jan-2010 | Completed | Startup |
Sagetis Biotech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Sagetis Biotech Patents
Sagetis Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| ES-2732762-A1 | Multicomponent nanoparticles and their use. (machine-translation by google translate, not legally binding) | Inactive | 25-May-2018 | ||
| GB-201708203-D0 | Chemical compounds | Inactive | 22-May-2017 | ||
| ES-2821796-T3 | Complexes of modified viral-based therapeutic agents and poly (beta-amino-esters) | Active | 22-May-2017 | ||
| AU-2018274622-A1 | Complexes of viral-based therapeutic agents and modified poly(beta-amino ester)s | Active | 22-May-2017 | ||
| AU-2018274622-B2 | Complexes of viral-based therapeutic agents and modified poly(beta-amino ester)s | Active | 22-May-2017 | A61K47/6901 |
Sagetis Biotech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Sagetis Biotech FAQs
-
When was Sagetis Biotech founded?
Sagetis Biotech was founded in 2010.
-
Where is Sagetis Biotech headquartered?
Sagetis Biotech is headquartered in Barcelona, Spain.
-
What is the size of Sagetis Biotech?
Sagetis Biotech has 2 total employees.
-
What industry is Sagetis Biotech in?
Sagetis Biotech’s primary industry is Biotechnology.
-
Is Sagetis Biotech a private or public company?
Sagetis Biotech is a Private company.
-
What is Sagetis Biotech’s current revenue?
The current revenue for Sagetis Biotech is .
-
How much funding has Sagetis Biotech raised over time?
Sagetis Biotech has raised $2.61M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
